scholarly journals Clinical presentation and management of patients with hyperadrenergic postural orthostatic tachycardia syndrome. A single center experience

2011 ◽  
Vol 19 (5) ◽  
pp. 527-531 ◽  
Author(s):  
Khalil Kanjwal ◽  
Bilal Saeed ◽  
Beverly Karabin ◽  
Yousuf Kanjwal ◽  
Blair P. Grubb
Keyword(s):  
Clinical Presentation ◽  
Postural Orthostatic Tachycardia Syndrome ◽  
Single Center ◽  
Single Center Experience

Epidemiology, clinical presentation and outcomes of venous thromboembolism: A single center experience over 6 years period

2015 ◽  
Vol 241 (1) ◽  
pp. e227
Author(s):  
H. Al-Thani ◽  
A. El-Menyar ◽  
A.S. kilyanni ◽  
P. Pillai ◽  
S. John ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Clinical Presentation ◽  
Single Center ◽  
Single Center Experience

scholarly journals Clinical presentation, management, and postnatal outcomes of fetal tachyarrhythmias: A 10-year single-center experience

2018 ◽  
Vol 11 (1) ◽  
pp. 34 ◽  
Author(s):  
Balu Vaidyanathan ◽  
Balaganesh Karmegeraj ◽  
Sushmita Namdeo ◽  
Abish Sudhakar ◽  
Vivek Krishnan ◽  
...  
Keyword(s):  
Clinical Presentation ◽  
Single Center ◽  
Single Center Experience

Bupropion in the treatment of postural orthostatic tachycardia syndrome (POTS): a single-center experience

2020 ◽  
Vol 68 (6) ◽  
pp. 1156-1158
Author(s):  
Rohit Vyas ◽  
Zeid Nesheiwat ◽  
Mohammed Ruzieh ◽  
Zaid Ammari ◽  
Mohammad Al-Sarie ◽  
...  
Keyword(s):  
Statistical Analysis ◽  
Gold Standard ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Postural Orthostatic Tachycardia Syndrome ◽  
Potential Treatment ◽  
Single Center ◽  
Single Center Experience ◽  
Dopamine Reuptake ◽  
Dopamine Reuptake Inhibitor

Postural orthostatic tachycardia syndrome (POTS) is estimated to impact millions of people each year. However, there is no established gold standard for its treatment. Bupropion is a norepinephrine and a dopamine reuptake inhibitor and has been implicated as a potential treatment for POTS. We performed a non-randomized retrospective chart review on 47 patients with POTS with statistical analysis evaluating for significant findings including reduced orthostasis and improvement of symptoms with the use of bupropion. Bupropion was not associated with a statistically significant improvement in orthostatic vitals but there was an overall reduction in reported syncope. While the use of bupropion does not show a statistically significant impact on orthostatic vitals in patients with POTS, it did show a degree of improvement in syncope and as such might be useful in patients with syncope-predominant POTS.

scholarly journals Papillary tumor of the pineal region: a single-center experience

2020 ◽  
Vol 7 (4) ◽  
pp. 384-390
Author(s):  
Christian Malte Boßelmann ◽  
Irina Gepfner-Tuma ◽  
Jens Schittenhelm ◽  
Cornelia Brendle ◽  
Juergen Honegger ◽  
...  
Keyword(s):  
Molecular Diagnostics ◽  
Clinical Presentation ◽  
Case Series ◽  
Treatment Recommendations ◽  
Pineal Region ◽  
Rare Entity ◽  
Single Center ◽  
Papillary Tumor ◽  
Single Center Experience ◽  
Neurosurgical Treatment

Abstract Papillary tumor of the pineal region (PTPR) is a rare entity. Its clinical presentation is diverse, and establishing an accurate and timely diagnosis may be challenging. Treatment recommendations are based on the evidence level of case series. Recently, several key advances have been made for immunohistochemical characterization, molecular diagnostics, and neurosurgical treatment of PTPR. Here, we describe our single-center experience.

Sign in / Sign up

Export Citation Format

Share Document